Whilst tankyrase catalytic inhibitors can suppress tumour cell growth, in-vivo studies have also pointed to different degrees of tankyrase-inhibitor-induced intestinal toxicity in mice35,39,41. This evidence concerns the gene TNKS and neoplasm.